reports
Hanjin Transportation Co: 1 director
A director at Hanjin Transportation Co bought 2,000 shares at 21,350.000KRW and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
APT Medical Inc: 1 director
A director at APT Medical Inc sold 188,695 shares at 471.120CNY and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
SMC Trading Investment JSC: 1 director
A director at SMC Trading Investment JSC sold 9,581,821 shares at 0.000VND and the significance rating of the trade was 90/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
CIC39 Corporation: 1 director
A director at CIC39 Corporation maiden bought 101,600 shares at 0.000VND and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
More Acquisitions on Horizon for Ladybug’s Growing E-Commerce Revenue ...
More Acquisitions on Horizon for Ladybug’s Growing E-Commerce Revenue Model TULSA, Okla., April 16, 2024 (GLOBE NEWSWIRE) -- In Tulsa, Oklahoma, on April 16, 2024, Ladybug Resource Group, Inc. (OTC PINK: LBRG) announced that the company is making strategic moves in the e-commerce space, with its subsidiary Growhouse Nutraceuticals Ltd., eyeing the acquisition of ‘Your Supplement Supply Store Ltd.'s’ primary website. This acquisition aims to bolster Ladybug's online footprint and is projected to generate an additional $2.25 million in annual revenue. Growhouse's focus on acquiring uniqu...
XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, A...
XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024 Webcast and Conference Call Scheduled for 5:00 PM ET NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that it will report results for the year ended December 31, 2023, on Tuesday, April 16, 2024, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m. ET. The Company encourages investors, and interested parties, to listen via webcast ...
Solid Power Announces Upcoming Investor Conference Schedule
Solid Power Announces Upcoming Investor Conference Schedule LOUISVILLE, Colo., April 16, 2024 (GLOBE NEWSWIRE) -- , Inc. ("Solid Power") (Nasdaq: ), a leading developer of solid-state battery technology, today announced it will participate in the following investor conferences in the coming months: Janney Fireside ChatPresentation date and time: April 17, 2024, 2:00pm ETLocation: Virtual Oppenheimer 9th Annual Emerging Growth ConferenceDate: May 9, 2024Location: Virtual JP Morgan Virtual Battery SeriesPresentation date and time: May 15, 2024, 10:00am ETLocation: Virtual TD Cowen’s 2nd...
Franklin Electric Schedules Its First Quarter 2024 Earnings Release an...
Franklin Electric Schedules Its First Quarter 2024 Earnings Release and Conference Call FORT WAYNE, Ind., April 16, 2024 (GLOBE NEWSWIRE) -- Franklin Electric Co., Inc. (NASDAQ: FELE) will release its first quarter 2024 earnings at 8:00 am ET on Tuesday, April 30, 2024. A conference call to review earnings and other developments in the business will commence at 9:00 am ET. The first quarter 2024 earnings call will be available via a live webcast. The webcast will be available in a listen only mode by going to: For those interested in participating in the question-and-answer portion of ...
Xtep International Holdings Ltd: 1 director
A director at Xtep International Holdings Ltd bought 1,457,500 shares at 4.445HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
NuCana Announces Completion of ADS Ratio Change
NuCana Announces Completion of ADS Ratio Change EDINBURGH, United Kingdom, April 16, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that the Company’s previously disclosed plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing one (1) ordinary share, to one (1) ADS representing twenty-five (25) ordinary shares (the "ADS Ratio") has been made effective. The ADS Ratio Change became effective on April 16, 2024 (the “Effective Date”). For the Company's ADS holders, the change in the ADS Ratio has the same effec...
ProPhase Labs Unveils Project ZenQ-AI
ProPhase Labs Unveils Project ZenQ-AI Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a biopharma, genomics, and diagnostics Company, today announced an innovative step forward in cancer treatment research with the introduction of Project ZenQ-AI. This project employs the Company’s state-of-the-art AI platform which was meticulously developed with leading AI technology platf...
Acumen Pharmaceuticals Presents First Comprehensive Clinical and Bioma...
Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting Presentation and poster include deeper data insights on sabirnetug safety profile, target engagement and fluid biomarker changesPresentation to be featured during AAN Emerging Science SessionCompany on track to initiate Phase 2 trial evaluating sabirnetug in first half of 2024 CHARLOTTESVILLE, Va., April 16, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that ta...
Westpac NZ Wins FICO Award After Successfully Adopting Platform and En...
SAN DIEGO--(BUSINESS WIRE)-- FICO World – FICO (NYSE: FICO) Highlights: Westpac NZ wins the 2024 FICO® Decisions Pioneer Award Westpac NZ increases customer engagement and process automation with FICO® Platform Partnership with FICO delivers greater agility and data-driven collections improvements Today at FICO® World, the industry’s leading analytic and AI event, has won the 2024 FICO® Decisions Pioneer Award, for using the industry-leading capabilities of to advance hyper-personalization and accelerate digital service innovation. The bank’s partnership with FICO has resulte...
LGI Homes Opens its First Community in St. Cloud, Minnesota Market
LGI Homes Opens its First Community in St. Cloud, Minnesota Market MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced that it has opened in the St. Cloud, Minnesota market with its new community, . Homeowners will enjoy the charm of small-town living paired with quick and convenient access to incredible big-city amenities. “We are excited to be in the St. Cloud market for the first time with our Parkside community located just 15 minutes from downtown St. Cloud. We offer customers brand-new, affordable homes with easy access to both St. C...
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Opt...
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings WILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that it has filed a provisional patent application pertaining to the recent advancements and optimizations Monopar has achieved with its MNPR-101 radiopharmaceutical program. The provisional patent titled “Antibody Radioisotope Constructs” that was filed with the United States Patent...
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Com...
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion’s Board of Directors SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery and development, announced Najat Khan, PhD, will be its Chief R&D Officer and Chief Commercial Officer. Dr. Khan will lead Recursion’s r...
Right on Brands Announces Major Product Line Expansion via HONEY® Bran...
Right on Brands Announces Major Product Line Expansion via HONEY® Brands DALLAS, April 16, 2024 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC company and a leading developer of a diverse range of hemp-based and THCA products, today announced a major expansion in its products line offered to Texas consumers. Via its recently formed majority owned subsidiary, California’s Best Products, Inc, the Company will begin marketing the super-premium products of HONEY® Brands throughout its growing network of retailers. “The addition of HONEY® branded products in...
Decklar to Apply for Management Cease Trade Order
Decklar to Apply for Management Cease Trade Order CALGARY, Alberta, April 16, 2024 (GLOBE NEWSWIRE) -- Decklar Resources Inc. (TSX-V: DKL) (OTC: DKLRF) (FSE: A1U1) (the “Company” or “Decklar”) announces that it intends to apply to the Alberta Securities Commission, (the “ASC”), under National Policy 12-203 - Management Cease Trade Orders (“NP 12-203”) requesting that a temporary management cease trade order (“MCTO”) be granted in respect of the late filing of the consolidated audited financial statements, management’s discussion & analysis and related officer certifications and its annual...
Absci to Report Business Updates and First Quarter 2024 Financial and ...
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024 VANCOUVER, Wash. and NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the first quarter before market open on Tuesday, May 14, 2024. Absci management will webcast a corresponding conference call beginning at 8:00 a.m. Eastern Time / 5:00 a.m. Pacific Time to discuss its business developments, financial a...
Charles River Laboratories Launches Alternative Methods Advancement Pr...
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated to developing alternatives to reduce animal testing. The initiative aims to drive the new standard for drug discovery and development and encapsulates the Company’s initial $200 million investment over the past four years and its five-year goal of investing an additional $300 million. This investment spans a portfolio of technology innovations, partnerships, and advocacy efforts to reduce...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.